Price (delayed)
$1.88
Market cap
$142.5M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.91
Enterprise value
$146.65M
atyr pharma (nasdaq: life) is engaged in the discovery and clinical development of innovative medicines for patients suffering from severe rare diseases using its knowledge of physiocrine biology, a newly
There are no recent dividends present for ATYR.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from and Sharadar.